For UK pharmaceutical and life sciences leaders
Your field team, medical affairs, and digital channels are telling HCPs three different stories
Siloed pharma marketing wastes a significant share of HCP engagement budget through duplication and conflicting messages, and the HCPs you most need to reach notice the inconsistency first.
Two minutes. Solva follows up with specific omnichannel integration options.
- HCPs receiving multiple, uncoordinated messages from different departments within the same pharmaceutical company
- Field reps unaware of digital campaigns or medical affairs activities targeting their key accounts
- Inefficient use of marketing technology stacks, with different teams using disparate systems
- Missed opportunities for personalised HCP engagement based on their preferences and previous interactions
- Increased internal friction and communication breakdowns between marketing, sales, and medical teams
- Slower adaptation to market changes and competitive pressures due to disjointed strategy execution
- Significant wastage of marketing budget on duplicated content and uncoordinated campaigns
- Reduced return on investment (ROI) for marketing spend due to ineffective HCP engagement and lower conversion rates
- Damage to the pharmaceutical company's brand image as a reliable and coordinated partner for HCPs
- Erosion of trust among HCPs due to perceived lack of understanding of their needs and preferences
90% of pharma marketers have at least 12 areas of budget responsibility (FiercePharma, 2025)
Frequently asked questions
Why does this problem persist?
UK pharma marketing has historically operated in silos: field force, medical affairs, digital, and market access each running separate programmes. HCPs experience this as fragmented and inconsistent communication. The most effective pharma companies in 2024 are those that have integrated these channels into a coherent omnichannel strategy.
What is the cost of leaving it unaddressed?
Siloed marketing wastes 30–40% of HCP engagement budget through duplication and conflicting messages. An integrated omnichannel approach typically reduces cost per HCP engagement by 25% while increasing prescribing conversion by 15–20%. (M3, 2024)
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.